[
    [
        {
            "time": "",
            "original_text": "创新百人说 | 独家对话张连山：传统药企转型速度偏慢，新阶段创新主流仍是 fast follow-on",
            "features": {
                "keywords": [
                    "传统药企",
                    "转型速度",
                    "创新",
                    "fast follow-on"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "创新百人说 | 独家对话张连山：传统药企转型速度偏慢，新阶段创新主流仍是 fast follow-on",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "一季度外资现身121只A股前十大流通股东：奥普特被外资买走流通盘一半；蓝筹股仍受青睐！",
            "features": {
                "keywords": [
                    "外资",
                    "A股",
                    "前十大流通股东",
                    "奥普特",
                    "蓝筹股"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "一季度外资现身121只A股前十大流通股东：奥普特被外资买走流通盘一半；蓝筹股仍受青睐！",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "恒瑞医药：这3类药贡献85%营收！创新药储备丰富！股价波动中，药企市值1哥能否再续辉煌？",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "营收",
                    "创新药",
                    "股价波动"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "恒瑞医药：这3类药贡献85%营收！创新药储备丰富！股价波动中，药企市值1哥能否再续辉煌？",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "上市药企2020年报解码：谁大把花钱做销售推广？谁重金搞研发？",
            "features": {
                "keywords": [
                    "上市药企",
                    "2020年报",
                    "销售推广",
                    "研发投入"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "上市药企2020年报解码：谁大把花钱做销售推广？谁重金搞研发？",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "上市药企2020年报解码，医疗器械公司净利增幅大",
            "features": {
                "keywords": [
                    "上市药企",
                    "2020年报",
                    "医疗器械",
                    "净利增幅"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上市药企2020年报解码，医疗器械公司净利增幅大",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]